Previous Page  10 / 14 Next Page
Information
Show Menu
Previous Page 10 / 14 Next Page
Page Background

Volume 7, Issue 1 (Suppl)

J Clin Exp Pathol

ISSN: 2161-0681 JCEP, an open access journal

Pediatric Pathology & Laboratory Medicine 2017

March 15-16, 2017

Page 45

Notes:

conference

series

.com

March 15-16, 2017 London, UK

12

th

International Conference on

Pediatric Pathology & Laboratory Medicine

Decline in frozen section diagnosis of sentinel lymph nodes for breast cancer as a result of theACOSOG

Z0011 trial

Statement of the Problem:

Results of the multicenter American College of Surgeons Oncology Group (ACOSOG) Z0011

trial published in 2011 showed that patients with early-stage breast cancer and limited sentinel lymph node (SLN) metastasis

treated with breast conserving surgery and systemic therapy did not benefit from axillary lymph node dissection (ALND).

The Z0011 trial was practice changing for the surgical management of breast cancer, and in turn, has proven to be equally

impactful on the pathologic diagnosis of SLNBs. The purpose of this study is to demonstrate the impact of the Z0011 trial on

intraoperative frozen section diagnosis of SLNBs.

Methodology &Theoretical Orientation:

This is a retrospective study reviewing pathology reports from patients with primary

breast cancer who met Z0011 trial clinical criteria and were initially treated with lumpectomy and SLNB from 2009 to 2015.

Findings:

SLNBs sent for frozen section diagnosis ranged from 68% to 100% before Z0011 and declined to just 2% of cases

after the Z0011 trial results were published in 2011. Of the post-Z0011 cases 19% had SLNs with metastasis and 97% of patients

were spared ALND.

Conclusion & Significance:

Following publication of the Z0011 trial results, intraoperative

frozen section diagnosis of SLNs significantly decreased at our institution. Given that the vast

majority of patients did not require second surgery for completion ALND, routine frozen

section diagnosis for SLNB can be safely avoided in patients who meet Z0011 criteria, sparing

patients the prolonged anesthesia time associated with waiting for frozen section diagnosis

results and decreasing health care costs related to extra charges incurred with frozen section

diagnosis.

Biography

Mary Ann G Sanders has received her Bachelor's degree from the University of Wisconsin-Madison. After she obtained her MD and PhD degrees from Washington

University in St. Louis, she completed an Anatomic Pathology and Clinical Pathology Residency at the University of Louisville followed by a Breast Pathology

Fellowship at the Brigham and Women’s Hospital, Harvard Medical School. She joined the Department of Pathology at the University of Louisville in 2011 as an

Assistant Professor and Breast Pathologist for James Graham Brown Cancer Center. She is an Associate Program Director for Pathology Residency Program at

the University of Louisville.

m0gime01@louisville.edu

Mary Ann G Sanders

University of Louisville, USA

Mary Ann G Sanders, J Clin Exp Pathol 2017, 7:1 (Suppl)

http://dx.doi.org/10.4172/2161-0681.C1.030